Prof. Amnon Peled and his team have screened 1322 FDA-approved drugs for their ability to treat COVID-19 induced Pneumonia using a unique High Throughput Screening assay developed at Prof. Peled's lab.
Several drugs were selected to undergo a phase II clinical trial at Hadassah and other medical centers.
1586128467.png)